NorthCoast Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
NorthCoast Asset Management's LLY Position: Q3 2021 in Review
NorthCoast Asset Management reduced its Eli Lilly (LLY) stake by 52% in Q3 2021, selling an estimated $2.61M and leaving 9,913 shares worth $2.29M. The position accounts for 0.08% of the portfolio, ranked #167.
NorthCoast Asset Management first reported a position in LLY in Q2 2013 and has held it in 19 quarters since. The position peaked at $44.6M in Q4 2013. 2,051 funds tracked by Wall St. Rank hold LLY as of Q3 2021.
- NorthCoast Asset Management held 9,913 shares of Eli Lilly worth $2.29M as of Q3 2021.
- NorthCoast Asset Management sold 10,584 Eli Lilly shares in Q3 2021, an estimated $2.61M.
- Eli Lilly made up 0.08% of NorthCoast Asset Management's portfolio in Q3 2021, its #167 holding.
- NorthCoast Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 19 quarters since.
- NorthCoast Asset Management's Eli Lilly position peaked at $44.6M in Q4 2013.
- 2,051 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.
Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.